The<unk>  therapies are being worked on mTOR receptors. Drugs like Everolimus have been developed to prove their efficacy especially with those associated with MEN 1 syndrome and help maintain glycemic control in people having an<unk> .
Insulinoma future or investigational therapies
Insulinoma medical therapy
Multiple endocrine neoplasia type 1 future or investigational therapies
Multiple endocrine neoplasia type 2 future or investigational therapies
Multiple endocrine neoplasia type 2 secondary prevention
Multiple endocrine neoplasia type 1 secondary prevention
Insulinoma surgery
Acromegaly radiation therapy